Lamivudine; tenofovir - Generic Drug Details
✉ Email this page to a colleague
Generic filers with tentative approvals for LAMIVUDINE; TENOFOVIR
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 300MG/300MG | TABLET; ORAL |
⤷ Sign Up | ⤷ Sign Up | 300MG; 300MG | TABLET; ORAL |
⤷ Sign Up | ⤷ Sign Up | 300MG; 300MG; 200MG | TABLET; ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
US Patents and Regulatory Information for lamivudine; tenofovir
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | TEMIXYS | lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 211284-001 | Nov 16, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma Ltd | LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 022344-001 | May 15, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Labs Ltd | CIMDUO | lamivudine; tenofovir disoproxil fumarate | TABLET;ORAL | 022141-001 | Feb 28, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |